High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug responseHui Gao, Zongyao Wang, Hongbo Cai et al.|Nature Medicine|2015Cited by 1.4k
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinasesYing-Nan P. Chen, Nicholas Keen, Matthew J. LaMarche et al.|Nature|2016Cited by 925
The metabolic function of cyclin D3–CDK6 kinase in cancer cell survivalHaizhen Wang, Piotr Siciński, Brandon Nicolay et al.|Nature|2017Cited by 354
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C. Townsend, Michelle A. Kelliher, Mark A. Murakami et al.|Cancer Cell|2016Cited by 304
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic disseminationMario Giuliano, Massimo Cristofanilli, Antonio Giordano et al.|Breast Cancer Research|2014Cited by 122